NO20013338L - Bis-aminosyresulfonamider inneholdende N-terminalt en substituert benzylgruppe som HIV-proteaseinhibitorer - Google Patents

Bis-aminosyresulfonamider inneholdende N-terminalt en substituert benzylgruppe som HIV-proteaseinhibitorer

Info

Publication number
NO20013338L
NO20013338L NO20013338A NO20013338A NO20013338L NO 20013338 L NO20013338 L NO 20013338L NO 20013338 A NO20013338 A NO 20013338A NO 20013338 A NO20013338 A NO 20013338A NO 20013338 L NO20013338 L NO 20013338L
Authority
NO
Norway
Prior art keywords
terminally
bis
amino acid
benzyl group
protease inhibitors
Prior art date
Application number
NO20013338A
Other languages
English (en)
Norwegian (no)
Other versions
NO20013338D0 (no
Inventor
Robert Frank Kaltenbach
George L Trainor
Original Assignee
Du Pont Pharm Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Du Pont Pharm Co filed Critical Du Pont Pharm Co
Publication of NO20013338D0 publication Critical patent/NO20013338D0/no
Publication of NO20013338L publication Critical patent/NO20013338L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06Dipeptides
    • C07K5/06008Dipeptides with the first amino acid being neutral
    • C07K5/06017Dipeptides with the first amino acid being neutral and aliphatic
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06Dipeptides
    • C07K5/06008Dipeptides with the first amino acid being neutral
    • C07K5/06017Dipeptides with the first amino acid being neutral and aliphatic
    • C07K5/06026Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atom, i.e. Gly or Ala
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/18Antivirals for RNA viruses for HIV
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06Dipeptides
    • C07K5/06191Dipeptides containing heteroatoms different from O, S, or N
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Virology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
NO20013338A 1999-01-13 2001-07-05 Bis-aminosyresulfonamider inneholdende N-terminalt en substituert benzylgruppe som HIV-proteaseinhibitorer NO20013338L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US11574699P 1999-01-13 1999-01-13
PCT/US2000/000820 WO2000042060A1 (en) 1999-01-13 2000-01-13 Bis-amino acid sulfonamides containing n-terminally a substituted benzyl group as hiv protease inhibitors

Publications (2)

Publication Number Publication Date
NO20013338D0 NO20013338D0 (no) 2001-07-05
NO20013338L true NO20013338L (no) 2001-09-13

Family

ID=22363180

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20013338A NO20013338L (no) 1999-01-13 2001-07-05 Bis-aminosyresulfonamider inneholdende N-terminalt en substituert benzylgruppe som HIV-proteaseinhibitorer

Country Status (15)

Country Link
EP (1) EP1140983A1 (xx)
JP (1) JP2002536298A (xx)
KR (1) KR20010101478A (xx)
CN (1) CN1336934A (xx)
AU (1) AU2725700A (xx)
BR (1) BR0007854A (xx)
CA (1) CA2353088A1 (xx)
CZ (1) CZ20012435A3 (xx)
HU (1) HUP0105235A3 (xx)
IL (1) IL143763A0 (xx)
NO (1) NO20013338L (xx)
PL (1) PL349774A1 (xx)
SK (1) SK9522001A3 (xx)
TR (1) TR200102033T2 (xx)
WO (1) WO2000042060A1 (xx)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1188766A1 (en) 1995-03-10 2002-03-20 G.D. Searle & Co. Bis-amino acid hydroxyethylamino sulfonamide retroviral protease inhibitors
US6861539B1 (en) 1995-03-10 2005-03-01 G. D. Searle & Co. Bis-amino acid hydroxyethylamino sulfonamide retroviral protease inhibitors
US7339078B2 (en) 1995-03-10 2008-03-04 G.D. Searle Llc Bis-amino acid hydroxyethylamino sulfonamide retroviral protease inhibitors
US6617310B2 (en) 2000-07-19 2003-09-09 Bristol-Myers Squibb Pharma Company Phosphate esters of bis-amino acid sulfonamides containing substituted benzyl amines
US20020022742A1 (en) * 2000-07-19 2002-02-21 Harris Gregory D. Salt forms of an HIV protease inhibitor
US20020022659A1 (en) * 2000-07-19 2002-02-21 Harris Gregory D. Crystalline and salt forms of an HIV protease inhibitor

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100336699B1 (ko) * 1992-08-25 2002-05-13 윌리암스 로저 에이 레트로바이러스 프로테아제 저해제로서 유용한히드록시에틸아미노 술폰아미드
EP0715618B1 (en) * 1993-08-24 1998-12-16 G.D. Searle & Co. Hydroxyethylamino sulphonamides useful as retroviral protease inhibitors
US6150556A (en) * 1995-03-10 2000-11-21 G. D. Dearle & Co. Bis-amino acid hydroxyethylamino sulfonamide retroviral protease inhibitors

Also Published As

Publication number Publication date
HUP0105235A2 (hu) 2002-04-29
EP1140983A1 (en) 2001-10-10
CA2353088A1 (en) 2000-07-20
PL349774A1 (en) 2002-09-09
NO20013338D0 (no) 2001-07-05
HUP0105235A3 (en) 2002-08-28
CZ20012435A3 (cs) 2002-02-13
AU2725700A (en) 2000-08-01
SK9522001A3 (en) 2002-03-05
TR200102033T2 (tr) 2001-12-21
KR20010101478A (ko) 2001-11-14
WO2000042060A1 (en) 2000-07-20
JP2002536298A (ja) 2002-10-29
BR0007854A (pt) 2002-01-15
CN1336934A (zh) 2002-02-20
IL143763A0 (en) 2002-04-21

Similar Documents

Publication Publication Date Title
DK1222192T3 (da) Hexahydrofuro-2,3-b furan-3-yl-N-3-(1,3-benzodioxol-5-ylsulfonyl)(isobutyl)amino-1-benzyl-2-hydroxypropyl-carbamat som retroviral proteaseinhibitor
NO20014483D0 (no) Aminderivater som proteaseinhibitorer
NO20031450L (no) Fumarsyrederivater som NF-kappa B inhibitorer
DK1460066T3 (da) Piperazinforbindelse som tachykinin-inhibitorer
NO20014642D0 (no) Aminopyrimidiner som sorbitol-dehydrogenase-inhibitorer
NO20031540D0 (no) Benzamidforbindelser som Apo-B-sekresjonsinhibitorer
DK0933372T3 (da) Sulfonamidderivater som prodrugs for aspartylproteaseinhibitorer
DK1244647T3 (da) Quinzolinderivater som VIGF-inhibitorer
DK1284974T3 (da) Triazolyltropanderivater som CCR5-modulatorer
NO20013850L (no) Sulfamat hydroksansyremetallproteaseinhibitor
NO20004696L (no) Kinoloner som serinproteaseinhibitorer
NO20030135D0 (no) Piperidinforbindelser for bruk som CCR-3 inhibitorer
ATE534622T1 (de) Aspartylprotease-inhibitoren
NO20033618D0 (no) Ftalayinon-piperidino-derivater som PDE-4-inhibitorer
NO994103D0 (no) Reverse hydroksamatderivater som metallproteaseinhibitorer
EE200400023A (et) Uued sulfoonhappe derivaadid
NO20013675L (no) 2,3,4,5-tetrahydro-1H-[1,4)benzodiazepin-3-hydroksamsyre som matriks-metalloproteinase-inhibitorer
NO20016201D0 (no) Tienopyrimidiner som fosfodiesteraseinhibitorer
NO20013853L (no) Heteroarylamidiner, metylamidiner og guanidiner som proteaseinhibitorer
NO20041819L (no) Diazacykloalakaner som oksytocinagonister
NO20013338L (no) Bis-aminosyresulfonamider inneholdende N-terminalt en substituert benzylgruppe som HIV-proteaseinhibitorer
AP1878A (en) Broadspectrum 2-amino-benzothiazole sulfonamide HIV protease inhibitors.
NO20003828D0 (no) 2,3,4,5-Tetrahydro-1H-[1,4]-benzodiazepin-3-hydroksamsyrer som matriks-metalloproteinaseinhibitorer
NO20024481D0 (no) Difluorbutyrsyre metalloproteaseinhibitorer
NO20023893L (no) Aminosyreforbindelser og deres anvendelse som NEP-, ACE- og ECE-inhibitorer

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application